GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
42.87
-0.12 (-0.28%)
At close: Mar 28, 2024, 4:00 PM
43.00
+0.13 (0.30%)
After-hours: Mar 28, 2024, 7:51 PM EDT

GSK Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2003
Net Income
4,92814,9564,3855,7494,6453,6231,5329128,4222,756
Upgrade
Depreciation & Amortization
00002,3342,1932,9391,9762,1931,659
Upgrade
Share-Based Compensation
000036500000
Upgrade
Other Operating Activities
1,840-7,5533,5672,6926762,6052,4473,609-8,046761
Upgrade
Operating Cash Flow
6,7687,4037,9528,4418,0208,4216,9186,4972,5695,176
Upgrade
Operating Cash Flow Growth
-8.58%-6.90%-5.79%5.25%-4.76%21.73%6.48%152.90%-50.37%-28.33%
Upgrade
Capital Expenditures
-1,286-997-818-940-1,170-1,176-1,264-1,445-1,308-1,149
Upgrade
Acquisitions
-1,407-3,22515424-3,525-95378477,258118
Upgrade
Change in Investments
2,00196582,857-188-158-12587273123
Upgrade
Other Investing Activities
-903-4,646-1,171220-471-124-545-458-186-170
Upgrade
Investing Cash Flow
-1,595-8,772-1,7772,161-5,354-1,553-1,443-1,2696,037-1,078
Upgrade
Dividends Paid
-2,247-3,467-3,999-3,977-3,953-3,927-3,906-4,850-3,874-3,843
Upgrade
Share Issuance / Repurchase
102521295174568973-71
Upgrade
Debt Issued / Paid
-2,567-4,824-2,184-4,2163,5158,124-990130-2,437228
Upgrade
Other Financing Activities
-8379,089-1,427-1,968-1,453-10,660-1,540-1,761-865-1,699
Upgrade
Financing Cash Flow
-5,641823-7,589-10,132-1,840-6,389-6,380-6,392-7,103-5,385
Upgrade
Exchange Rate Effect
-99152-29-39-828-100283-4584
Upgrade
Net Cash Flow
-468-546-1,414470826479-905-1,1641,503-1,287
Upgrade
Free Cash Flow
5,4826,4067,1347,5016,8507,2455,6545,0521,2614,027
Upgrade
Free Cash Flow Growth
-14.42%-10.20%-4.89%9.50%-5.45%28.14%11.92%300.63%-68.69%-33.77%
Upgrade
Free Cash Flow Margin
18.08%21.85%28.89%30.80%20.29%23.51%18.73%18.11%5.27%17.50%
Upgrade
Free Cash Flow Per Share
2.703.183.563.763.453.652.882.590.652.07
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).